The human mannose-binding protein functions as an opsonin by unknown
THE HUMAN MANNOSE-BINDING PROTEIN
FUNCTIONS AS AN OPSONIN
BY MARCELLA KUHLMAN,* KEITH JOINER,1 AND R. ALAN B. EZEKOWITZ"
From the `Division of Hematology/Oncology, HarvardDepartment of Pediatrics,
Children's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts 02115;
and the $Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Disease,
National Institutes of Health, Bethesda, Maryland 20892
Phagocytes play a key role in host defense against bacterial invasion. Bacterial
clearance is mediated in large part byphagocytosis viadistinct receptors fordifferent
isotypes of Ig (FcR) and fragments of the third component of complement (CR,
CR3) (reviewed in references 1, 2). Although these receptors recognize antibody-
and complement-coated organisms, respectively, they may also directly engage cer-
tain microorganisms in the absence ofadded opsonins (3, 4). Lectin-like molecules
on the surface ofbacteria can mediate adhesion to phagocyte cell surface glycopro-
teins(5-8). Conversely, opsonin-independent phagocytosis can alsooccurviaphagocyte
lectin-like receptors that recognize specific configurations ofcarbohydrate on target
organisms. Thephagocytelectin-likereceptorsincludethe/3glucan receptoronmono-
cytes (9) and a 170-kD macrophage-specific mannose receptor (MR)' expressed on
the surface oftissue macrophages but not on circulating phagocytes (10, 11). En-
gagement ofmannose-rich particles like zymosan by the MR (12) results in engulf-
ment of the particles and the release ofbiologically active secretory products such
as reactive oxygen intermediates (13), arachidonate metabolites (14), and neutral pro-
teinases (15). Although the MR may recognize certain configurations ofhigh man-
nose glycans expressed on the surface of some bacteria (16-18), yeasts, and fungi
(19), experiments performed with Leishmania donovani provide the clearest evidence
forinvolvement oftheMR incell bindingand uptake ofapathogenic microorganism.
Although circulating monocytes do notexpress the MR (10), there exists in serum
a mannose-binding protein which shares similar binding characteristics and cross
reactive epitopes with the MR. The mannose binding protein (MBP) was first iso-
lated from the serum ofrabbits (20) and subsequently found in the serum and liver
ofhumans and rodents (21-26). Analysis ofthe human MBP, like its two rat homo-
logues (27), reveals that the protein is divided into three domains: a cysteine-rich
NH2-terminal domain that stabilizes the a-helix ofthe second collagen-like domain,
and athirdCOOH-terminalcarbohydrate bindingregion (28). Thefunction ofMBP
is unknown, although a role in host defense is suggested by its ability to bind yeast
mannans (20) andour finding (29) that MBPprevents infection ofH9 lymphoblasts
This work wassupported by National Institutes of Health grant ROI-AI-23786 and by aGrant-in-Aid
from the Squibb Medical Foundation. Addresscorrespondence to Dr. Alan Ezekowitz, HarvardMed-
ical School, TheChildren's Hospital, 300Longwood Ave., Ender's Building,7thfloor, Boston, MA 02115.
1 Abbreviations used in this paper: MBP, mannose binding protein; MR, mannose receptor.
TheJournal of Experimental Medicine " Volume 169
￿
May 1989
￿
1733-1745
￿
17331734 HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN
by HIV by binding to the high mannose glycans expressed on the envelope glyco-
protein of HIV (17, 30). Further, MBP synthesis by liver is induced as part of the
acute-phase response (28) and its in vitro synthesis also appears to be upregulated
by cytokines (Ezekowitz, R. A. B., unpublished data) . We hypothesized that MBP
would serve an opsonic role in serum and thereby enhance clearance of mannose-
rich pathogens by phagocytes.
We investigated this idea using strains of salmonella that vary in the amount of
mannose within their cell wall LPS. Enteric Gram-negative bacteria bear LPS con-
taining one copy per molecule of lipid A and core oligosaccharide regions, and a
variable number of 0-polysaccharide repeating units extending from the core-
oligosaccharide. In Salmonella montevideo, each repeating subunit contains four man-
nose residues with one galactose and one N-acetylglucosamine (31). Enteric bacteria
that lack 0-polysaccharide (rough phenotype) are generally avirulent. These organisms
are readily cleared from the circulation ofexperimental animals, are avidly ingested
by phagocytes, perhaps due to direct binding to adhesion molecules on the phago-
cyte surface, and are directly killed by complement. A critical density of 0-poly-
saccharide (smooth phenotype) masks cognate epitopes on the outer membrane for
cell surface phagocyte adhesion molecules (4), outer membrane-specific bacterio-
phages (32), and core-specific antibodies(33). Perhaps more importantly, the 0-poly-
saccharide confers resistance to complement-mediated killing (reviewed in reference
34). Enteric bacteria bearing 0-polysaccharide within LPS are relatively resistant
to host defences and therefore provide a physiologically relevant target to test our
proposed role for MBP in host defence.
In this report we demonstrate that purified native and recombinant MBP bind
to wild-type S. montevideo expressing the mannose-rich 0-polysaccharide. Interac-
tion of MBP with these organisms results in attachment, uptake and killing of the
opsonised bacteria by phagocytes. MBP does not bind to a Salmonella mutant that
is incapable of synthesizing complete LPS in the absence of added galactose and
mannose. However, when this mutant is growth with exogenous D+ galactose and
D+ mannose, complete LPS-containing mannose-rich 0-polysacchride is synthe-
sized, and the organism is readily opsonized by MBP.
Materials and Methods
Reagents.
￿
D-mannose, ferricytochrome c, n-galactose, yeast mannan, PMA were obtained
from Sigma Chemical Co., St. Louis, MO. '[H]-D-glucose and 1251 sodium iodide were ob-
tained from Amersham Corp. (Arlington Heights, IL).
Purification ofHuman MBP .
￿
MBP was isolated from serum as described (26, 29). Briefly,
plasma from ill patients undergoing plasmapheresis was recalcified to 20 mmol CaC12 and
incubated with mannan-Sepharose beads overnight at 4°C. After extensive washing, the column
was eluted with 10 mmol Tris, 2 mmol EDTA and the peak was identified. After recalcification,
the pooled samples were passed down a smaller mannan-Sepharose column and eluted with
Tris-buffered saline plus 10 mmol calcium chloride (TBS-CaC12) + 50 mmol D-mannose.
The purity of the eluted protein was assessed on an 117o SDS-polyacrylamide Laemmli gel
and biological activity assayed by using '25Nabeled mannose-BSA glycoconjugate as de-
scribed (35).
Preparation ofCells.
￿
Polymorphonuclear leukocytes (PMNs) were isolated from peripheral
blood ofhealthy volunteers and neutrophils were separated on a Ficoll hypaque gradient and
were further purified from the pellet by hypotonic lysis of erythrocytes as described (10).
Monocytes were purified on a Ficoll hypaque gradient and further purified from otherKUHLMAN ET AL.
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mononuclear cells by agglutination at 4°C and passage through a 3-ml column ofFCS. Anal-
ysis of the population revealed <l0o7o CD3' cells and >90To of cells expressed mature mac-
rophage marker LeuM3. In some experiments, monocytes were further purified by adher-
ence on glass Labtek slides as described elsewhere (10).
Bacterial Strains.
￿
Wild-type Salmonella montevideo (strain SH5770, tm-mv hybrid rfc 0-6,
7) (provided by Helena Mikela, National Public Health Institute, Helsinki, Finland) was cul-
tivated overnight at 37°C in 5 ml of LB broth. The strain produces a mannose-rich 0-poly-
saccharide within its LPS (31). The bacterial culture was diluted 1 :10 in fresh LB broth and
grown in the presence of 50uc/ml [3H]glucose. At midlog phase (OD66o = 0.5, 4-5 x 108
CFU/ml) the cells were washed three times in HBSS plus 0.1% gelatin containing 10 mmol
CaC12 (GHBSS). The bacteria were then resuspended in 2 ml of GHBSS to a specific ac-
tivity of 5 x 105 cpm/5 x 108 bacteria. A mutant of S. montevideo (SL5222 mv-P14, lysogen
Hbc pmc462, gal E715) (36) was used in some experiments. This strain is deficient in UDP
galactose epimerase and phosphomannose-isomerase. When grown in the absence of exoge-
nous galactose or D+mannose, these mutations prevent, respectively, the synthesis of com-
plete core oligosaccharide and 0-polysaccharide, resulting in production ofa rough Rc chemo-
type isolate. This rough strain is nonpathogenic and susceptible to complement lysis (34).
When SL5222 is in the presence of 5 mmol mannose and 5 mmol galactose, complete core
oligosaccharide is produced. The 0-polysaccharide is identical to the wild-type strain SH5770.
For experiments reported here, we compared SL5222 grown in the absence or the presence
of galactose and mannose. To standardize assays and to prevent piliation, only bacteria in
the log phase of growth were used. Electron micrographs of representative samples of bac-
teria revealed the absence of pili (not shown), thereby avoiding the possible complication of
lectin phagocytosis (37).
Binding ofMBP to Bacteria.
￿
200 tut of GHBSS containing 10' bacteria was prepared. The
bacteria were then incubated at 4°C with 20 lug/ml ofpurified native human MBP or 1 Fig/ml
of recombinant human MBP (described below). Binding assays were done in the presence
or absence of 10 mg/ml of yeast mannan that binds MBP with high affinity and serves as
a competitive inhibitor. After incubation for 30 min, the bacteria were washed five times in
GHBSS + 10 mmol CaC12 at room temperature in a microfuge at 1,300 g for 3 min. There-
after, a 1 :1,000 dilution of rabbit anti-human MBP antiserum was incubated with the bac-
teria for 1 h in PBS + 5% FCS and 10 mmol CaC12 and then the bacteria were washed three
times in GHBSS + 10 mmol CaC12 plus 0.05% Tween 20. Binding of anti-human MBP
to bacteria was detected by a 1 :1,000 dilution of goat anti-rabbit IgG conjugated to rhoda-
mine (Fisher Pharmaceuticals, Orangeburg, NY). After incubation, the bacteria were washed
five times in GHBSS + 10 mmol CaC12 plus 0.05% Tween 20, smeared onto glass slides
and allowed to air dry. Thereafter, bacteria were fixed with 100% ice cold methanol for 5
min. A rabbit antiserum raised against SH5770 served as a positive control for binding of
primary step antibody. Negative controls included the absence of MBP, no first step anti-
body, and preincubation of MBP with mannan before addition to the bacteria. Numerous
fields of triplicate assays were examined by fluorescence microscopy.
Association ofRadiolabeled Bacteria with Cells.
￿
10' radiolabeled wild-type and mutant strains
of bacteria were resuspended in 200 pl of GHBSS + 10 mmol CaC12 and were incubated
with varying concentrations of native MBP ranging from 2 ug/ml to 40,ug/ml at 4°C for
30 min. In all assays some aliquots of MBP were preincubated with 10 mg/ml yeast mannan
before addition to the bacteria. The bacteria were then washed three times in GHBSS +
10 mmol CaC12 for 3 min at room temperature in a microfuge at 1,300 g, resuspended in
50,ul of GHBSS and added to a 1-ml suspension containing either 106 PMNs or monocytes
(GHBSS). The bacteria and phagocytes were gently rocked at 37°C for 20 min and thereafter
the unattached bacteria were removed by five washes using differential centrifugation at 82 g
in a microfuge. Before the last wash, an aliquot from each sample was plated on a Labtek
slide and cells were adhered for 10 min, fixed in methanol, stained with Geimsa, and scored
by light microscopy. To score the cells plated on the Labtek slides, at least 400 cells were
counted. The phagocytic index represented the number ofattached or ingested particles per
100 PMNs. The pellet from above containing cells and radiolabeled bacteria was then lysed
in 100 A.1 PBS + 0.5% Triton X-100 and the radioactivity was measured in a scintillation1736 HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN
spectometer (Packard Instrument Co., Inc., Downer's Grove, IL). Nonspecific radioactivity
of the buffer alone was subtracted. All assays were performed in triplicate.
Bacterial Killing.
￿
To assess whether opsonization ofS. montevideo SH5770 by MBP enhanced
the killing of bacteria by PMNs and monocytes, we performed a bacterial killing assay that
is a slight modification on a method described by C. Farber and C. Nathan (manuscript in
preparation). Bacteria were grown up to midlog phase (OD62o = 2.0 x 109 CFU/ml) and
3.0 x 108 CFU were incubated at 4°C for 30 min with either MBP (10 hg/Al) or MBP (10
Icg1jAl) + mannan (10 mg/Al). Bacteria, bacteria + MBP, or bacteria + MBP + mannan
were washed twice and resuspended in 20 I1 of GHBSS and added to 2 x 106 PMNs or
monocytes that had been plated in a 96-well plate to make up a final volume of 50 11. Three
wells were prepared for each time point and the plate was incubated on a shaking platform
at 37°C for either 1 or 2 h. For time 0, control bacteria alone were incubated in triplicate.
At the appropriate time, 200 Fcl of ice cold water containing 0.1% Triton X-100 was added
per well. The contents of each well were agitated by repeated pipetting and then 22 JAI was
removed from each row using a multiloader pipetteman and added to a second microliter
plate containing 200 Fcl of M63 medium (7 g potassium phosphate [dibasic], 3 g potassium
phosphate [monobasic], 2 g ammonium sulphate, 0.5 ml of ferrous sulphate solution [1.83
mg/ml]). By repeating this step a fivefold dilution was prepared. Then 20 pl of each serial
dilution was plated in duplicate on LB agar plates and incubated overnight at 37°C. Colonies
were quantitated in those dilutions that had grown 30 to 300 CFU. The log of CFU/ml was
calculated and subtracted from the control which was bacteria alone.
Superoxide Assays.
￿
The ability of S. monteaideo SH5770 opsonized by MBP to trigger su-
peroxide release by 106 PMNs or monocytes was measured by a discontinuous assay of su-
peroxide dismutase-inhibitable reduction of ferricytochrome c, as previously described (10),
or histochemically by reduction of nitroblue tetrazolium (10).
Preparation ofRecombinant Human MBP.
￿
A truncated cDNA representing the coding re-
gion of the human MBP was inserted into the Eco RI site of the polycistronic expression
vector, pMTADA (38) (a gift from Dr. R. Kaufman, Genetics Institute, Cambridge, MA
02140). Chinese Hamster Ovary cells were transfected with the vector containing the MBP
coding region by protoplast fusion using polyethylene glycol 1000 (J . T. BakerChemical Co.,
Phillipsburg, NJ). Transfectants were selected and amplified as described (38) . Four clones
synthesized recombinant MBP as assessed by RNA analysis and immunoprecipitation of
radiolabeled supernatants with antibody to MBP (not shown). Cells from one clone were
expanded and grown to confluence in ten 100-mm tissue culture dishes. Thereafter the fetal
calfcontaining medium was removed and the cells were incubated overnight with DME plus
1% BSA. Recombinant MBP was purified from 100 ml of pooled medium collected from
the 10 dishes by elution from a mannan-Sepharose affinity column with TBS-CaC12 and 50
mmol mannose. The purity of the material was assessed by PAGE and immunoblot as de-
scribed (29).
Results
Human MBP Binds Selectively to Salmonella monteaideo SH5770 Bearing Mannose-rich
0-antigen Polysaccharide. We first sought to assess MBP binding to wild-type and
mutant strains of S. monteaideo varying in mannose content within LPS. The results
shown in Fig. 1 A demonstrate that MBP selectively recognizes SH5770, which has
amannose-rich polysaccharide. Thebinding ofMBP is abrogatedby preincubation
of MBP with mannose-rich yeast mannan (Fig. 1 C). Interestingly, if mannan and
MBP areaddedsimultaneously to thebacteria, only partialinhibition of MBPbinding
is observed (not shown). This suggests that the configurations of high mannose on
yeast mannan andbacteria are recognized with similaraffinity by MBP. TheSL5222
mutant of S. monteaideo, when grown in the absence of galactose and mannose and
hence lacking complete core oligosaccharide and all O-polysaccharide is not recog-
nized by MBP (Fig. 1 E). When grown in the presence of galactose and mannose,KUHLMAN ET AL .
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FIGURE 1 .
￿
Binding ofMBP to Salmonella
montevideo . Binding ofMBPwas detected
by anti-MBP serumandarhodamine goat
anti-rabbit IgG . (A) Binding to the wild-
type 0-polysaccharide bearing SH5770
strain. (C) Inhibition ofMBP binding to
SH5770 by 10 mg/ml yeast mannan . (E)
Lack of binding ofMBP to the mutant
strain SH5222 grown underconditions (no
galactose or mannose) precluding 0-poly-
saccharide synthesis. (G) MBP binding
to SL5222 grown in galactose and man-
nose, resulting in synthesis of mannose-
rich O-polysaccharide. (B, D, F, H, and
1) Light micrographs of the same fields .
No fluorescence was observed in the ab-
sence ofMBP oranti-MBPantiserum(not
shown) . These results are representative
of five independent experiments .
however, these bacteria synthesize complete core oligosaccharide and an 0-polysac-
charideidentical to wild type bacteria and arerecognized byMBP (Fig. 1 G) . SL5222
grown in galactosealonepermitting complete core oligosaccharide synthesis showed
dim fluorescence . SH5770 alone in the absence ofMBP displayed no specific fluores-
cence (not shown) .
MBP-dependentBindingand Uptake ofS . montevideo SH5770 byPMNs.
￿
We next sought
to determine ifMBPmediated bindingof mannose-richS montevideo to neutrophils.1738 HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN
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FIGURE 2.
￿
Specific MBP-dependent uptake ofradiolabeled
S . montevideo by neutrophils. (l]) Bacteria opsonized with
varying concentrations of MBP; (O) inhibition of MBP-
mediated opsonization of bacteria by 10 mg/ml of yeast
mannan. Results show the mean of triplicate samples for
each time point from one experiment and are representa-
tive of nine independent experiments.
Approximately 10' radiolabeled SH5770 (mannose-rich O-polysaccharide) were
preincubated with increasing amounts of MBP and added to 106 PMNs. After 20
min at 37°C the non-cell-associated bacteria were removed by differential centrifu-
gation and cell-associated radioactivity was measured. MBP enhanced the binding
and uptake of bacteria in a dose-dependent manner that was maximal at 30 fig/ml
of MBP (Fig. 2) . These results were highly reproducible and are representative of
nine independent assays usingmultiple batchesof MBP. Preincubation of MBP with
10 mg/ml yeast mannan competitively inhibitedtheability ofMBP to bind the bac-
teria (Fig. 1) and abrogated the opsonic role of MBP. Association of bacteria with
cells was also assessed visually on preparations stained with Wrights/Giemsa. Bac-
teriaopsonised by MBPhad aphagocytic index(numberofcell associated bacteria/100
PMN) of 740 ± 50 compared with 55 ± 15 forbacteria alone. Although themajority
of cell associated bacteria appeared to be intracellular, we did not attempt to rigorously
distinguish between attached and ingested organisms.
MBPMediates Binding and Uptake of SL5222 Mutants Only if They Are Grown in the
Presence of Exogenous D (+) Mannose and D + Galactose. The requirement for man-
nose within the 0-polysaccharide for binding of MBP-coated Salmonella to PMN
was tested next. SL5222 is a mutant (described in Materials and Methods) which
when grown in the absenceofexogenous galactose and mannosehasa"rough" pheno-
type and is not recognized by MBP (Fig. 1 E). We, like others (4), found that these
bacteria bind directly to PMNs but are poorly phagocytosed in the absence ofserum
(Fig. 3 A). In addition, we show that this binding is not enhanced by MBP and
is unaffected by mannan (Fig. 3 A). However, if SL5222 is grown in the presence
of galactose and mannose, the core oligosaccharide is covered by the mannose-rich
0-polysaccharide (smooth LPSphenotype) and direct recognition by PMNs is greatly
reduced (Fig. 3 B). Addition of MBP, which binds directly to SL5222 grown under
these conditions (Fig. 1 G) enhances bacterialbinding anduptake fivefold by PMNs
(Fig. 3 B). Total uptake in the presence of MBP was similar to that described above
for the wild-type SH5770 strain of S. montevideo-bearing MBP The MBP-dependent
binding and uptake of bacteria is in large part inhibited by preincubation of MBP
with 10 mg/ml of mannan.
MBP Enhances Uptake andBinding of SH5770 by Monocytes.
￿
We next assessed theP A
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FIGURE 3 .
￿
(A) MBP does not affect at-
tachment of Salmonella SL5222 grown
without mannose and galactose (rough
LPS phenotype) . (B) Salmonella SL5222
when grown in the presence of galactose
andmannose, has a mannose-rich 0-poly-
saccharide that reduces direct recognition
byPMNs . However, 20 ug/ml ofMBP en-
hances binding and uptake of these bac-
teria . The MBP dependent opsonization
is inhibited 50% by 10 mg/ml of yeast
mannan . The results shownare the mean
determinants oftriplicate samples for each
treatment from one experiment and are
representative of six independent ex-
periments.
MBP-dependent binding and uptake of wild-type S monteaideo SH5770 by human
monocytes . Fig . 4 shows that 20 Wg/ml ofMBP significantly enhanced the uptake
ofSH5770 by monocytes in suspension and this activity wasalmost entirely abrogated
by preincubation ofMBP with 10 mg/ml ofmannan . In some experiments the mono-
cytes were adhered for 1 h on glass Labtek slides . Thereafter the nonadherent cells
were removed and bacteria were added after preincubation with or without MBP
in thepresence or absence ofmannan . Quantitative analysis using radiolabeled bac-
teria gave similar results (data not shown) to suspension assays,, as shown in Fig.
4 . There were at least fiveMBP opsonized bacteria associated with the vast majority
(90%) of monocytes, as detected by specific immunofluorescence (Fig . 4, inset) . No
phagocytosis was observed ifMBP was omitted .
RecombinantHuman MBPIsan Opsonin.
￿
The ability ofrecombinantMBP to serve
as an opsonin was tested next . The MBP mRNA in stably transfected CHO cells
was amplified several hundredfold when compared with the constitutive levels ob-
served in human hepatoma cells HepG2 (not shown) . MBP expressing CHO cells
were metabolically labeled with [35S]cysteine and [35S]methionine for 4 h and chased
FIGURE 4.
￿
Specific uptake by monocytes of radiolabeled
S . monteoideo opsonizedby 20 p.g/ml ofMBP (InsetA) Fluores-
cence staining of MBP-coated bacteria within monocytes
as detected by a rabbit anti-MBP antiserum and a
rhodamine-coupled goat anti-rabbit IgG . (Inset B) Phase
contrast microscopy of the same field. Results shown are
themean oftriplicate samples for each treatment from one
experiment and are representative ofthree independent ex-
periments .1740 HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN
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FIGURE 5 .
￿
Specific rMBP mediated uptake of S . mon-
tevideo by monocytes . Bacteria were radiolabeled with
[3H]glucose and incubated with rMBP with or without
mannan as described in Materials and Methods . The
results represent the mean from triplicate samples ofone
experiment and are representative ofthree independent
experiments .
overnight with medium containing excess unlabeled cysteine and methionine and
immunoprecipitation with anti-MBP antibody revealed a 32-kD under protein
reducing conditions . Supernatant containing recombinantMBPwas collected under
serum-free conditions from CHO cells that stably expressed MBP and MBP was
purifiedon a mannan sepharose column . The eluted material co-migrated with na-
tive protein purified from serum at an apparent molecular weight of 32 x 103 (not
shown) .
Like native MBP, recombinantMBP bound specifically to SH5770 (Fig . 11) and
binding was inhibited by 10 mg/ttl of yeast mannan (not shown) . Radiolabeled bac-
teria were then preincubated with rMBP with and without mannan and added to
PMNs . rMBP, like the native MBP, enhanced the uptake ofS . montevideo into mono-
cytes (Fig. 5) and activity was totally abrogated in the presence of 10 mg/ml of yeast
mannan . The above results indicate that rMBP is functionally equivalent to native
MBP in binding to and opsonizing S . montevideo for ingestion by PMNs .
FIGURE 6.
￿
S. montevideo opsonized with nativeMBPmediate reduction of nitroblue tetrazolium
by PMNs. (A)S . montevideo opsonized with MBP triggered NBT reductionbyPMNs . Quantita-
tive assays reveal superoxide dismutase inhibitable 02 - release was 12 t 3 nmol 02-/106 PMNs
for5min . (C) S . montevideo alone failed to triggerPMNreduction ofNBT (B)MBPalone failed
to trigger PMN reduction of NBT .LOG KILLING OF S. MONTEVIDEO
N
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FiGUeg 7.
￿
Logkilling by PMNs and mono-
cytesof bacteria opsonized with native MBP.
The ordinate represents the log of CFU/ml
on input bacteria (3 x 108 CFU/ml) minus
the log of CFU/ml of bacteria cultivated for
1 h at 37°C after indicated treatments. MBP
+ bacteria = 2.5 x 108 CFU/ml; PMN +
bacteria = 1.5 x 108CFU/ml; PMN + bac-
teria + MBP = 4.5 x 106 CFU/ml; mono-
cytes (mc) + bacteria = 1.7 x 108CFU/ml;
MC + bacteria + MBP = 7.5 x 106
CFU/ml. The standard deviations are the
mean ofvalues of three wells per time point
plus or minusthestandard deviation. Theex-
perimentsshown are representative of three
independent experiments.
S. Montevideo OpsonizedwithMBP TriggertheRespiratoryBurst.
￿
The capacity ofMBP
to elicit an oxidative burst from PMNs was tested . Respiratory burst activity was
determined histochemically in individual cells by means ofnitroblue tetrazolium
reduction assays. S Montevideo opsonized with MBP scored positive (Fig. 6 A), but
no activity was observed when cells were incubated with bacteria alone (Fig. 6 C)
or MBP alone (Fig. 6 B). Quantitative assays of superoxide production by pooled
cells revealed that S Montevideo opsonized with MBP resulted in the release of 12
t 3 nmol 02/106 PMNs for 5 min, whereas PMNs incubated with either bacteria
orMBP alonedidnot releaseany detectable superoxide. The maximum release trig-
gered by PMA was 29 ± 2 nmol 02/106 PMNs for 5 min.
MBPEnhancesKillingofS Montevideo byPMNs.
￿
Wenext determined whether phago-
cytekillingofMBP opsonized bacteria wasenhanced. Opsonization ofS Montevideo
by MBP resulted in a 1.8 t 0.2 and 1.6 t 0.1 log killing by PMNs and monocytes
respectively after 1 h incubation at 37°C (Fig. 7). In the absenceofphagocytes, MBP
agglutination ofbacteria did occur to some extent. This may account for the small
but reproducible reduction in CFU/ml from 3.0 x 108 at time 0 td 2.5 x 108
CFU/ml at 1 h. There was measurable but low killing of bacteria in the presence
ofphagocytes and in the absence ofMBP No enhanced killing was observed at the
2-h time point and mannan abrogated the MBP effect (not shown).
Discussion
In this study wedemonstrate that purified human MBP and recombinant human
MBPbind selectively towild-typeS Montevideo that expressesamannose-rich 0-poly-
saccharide. In contrast, MBP does not bind to nonpathogenic mutants ofS Monte-
video that lack the mannose-rich 0-polysaccharide within LPS. MBP enhances at-
tachment, ingestion, andkillingofthebacteria byphagocytes, suggesting that MBP
has arole in host defenseagainstpathogens bearing surface-exposed mannoseresidues.
The selective binding of MBP to the mannose-rich 0-polysaccharide of LPS is
evident from the experiments with mutant strains ofS. Montevideo that lack the en-
zymes galactose epimerase andphosphomannose-isomerase. When grownin the ab-
sence ofexogenous D+ galactose or D+ mannose, these bacteria are unable to as-
semble polysaccharide side chains (36, 39) on their outer surface and do not bind1742 HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN
to MBP (Fig. 1 E). However, ifexogenous substrate is added, they assemble a mannose-
rich 0-polysaccharide that is similar to the wild type S. montevideo and are recog-
nized by MBP (Fig. 1 G).
The 0-polysaccharide confers resistance to the bacteria against several host de-
fense mechanisms. It masks the determinants on the LPSthat mediate direct recog-
nition by phagocytes (4). 0-polysaccharide decreasesaccess to core-specific antibodies
andphages (33, 40) andconfers resistance to complement-mediated lysis (39). However,
presence of the 0-polysaccharide is an absolute requirement for substantial MBP
opsonization and illustrates the physiological role for MBP in host defense. Killing
of the organisms can be explained in large part by the release of reactive oxygen
metabolites to which the bacteria are known to be sensitive.
MBP appears to selectively recognize high mannose glycans found on the surface
of bacteria, yeasts, and the envelope glycoprotein of certain viruses, such as HIV
(41). The engagement of ligand may result in aconformational change of the MBP
molecule, like Clq (42), to which it has an analogous structure (27, 28), thereby
enabling recognitionby cell surface receptor(s). In the absence of ligand, MBPdoes
not bind to the surface of cells implying that the configurations of carbohydrates
normally exposed on cell surface glycoproteins are not recognized by MBP This
selectivity contrasts with nonvertebrate mannose lectins, like the plant lectin Con
A(43) andmannose-sensitive bacterial adhesins foundon the pili ofsome stationary
phase bacteria (37). It is not surprising that the binding specificities of Con A and
MBP should differ as these two proteins bear no structural homology (28, 44) to
one another and illustrate that thevertebrate host defense molecule hasamore defined
specificity than its more primitive counterparts, Con A and bacterial adhesins.
As yet we have not identified the cellular receptor or receptors that mediate up-
take ofMBP opsonized bacteria. The structural analogy ofMBP with the first com-
plementcomponent Clq suggests that theClqreceptor (45, 46) may be alikely can-
didate as are members of the integrin family of molecules to which CR3 belongs
(47). Experiments are in progress to assess the relative contributions of these and
or other receptor(s) in MBP-mediated phagocytosis.
Although theexperimentswith MBPreported in this manuscript were performed
in the absence ofserum, MBP most likely functions in conjunctionwith other serum
moleculesin host defense. In particular, MBP is able to enhance complement depo-
sition on mannan-treated erythrocytes (48), suggesting a cooperative role for MBP
and complement. Furthermore, MBP enhances complement deposition on man-
nose bearing isolates of Salmonella (Schweinle, J., A. Ezekowitz, M. Kuhlman, and
K. Joiner, manuscript submitted for publication). These results emphasize that in
the bloodstream and at inflammatory sites MBP and complement molecules most
likely cooperate in opsonization and clearance of particles by phagocytic cells.
This studydemonstrates that vertebrate lectin-like proteins that recognizecertain
configurations of mannose oligosaccharides have a key role in host defense against
some microorganisms. MR' macrophages form a lattice beneath epithelial surfaces
guarding the portalsof maximum antigen entry. In these and other tissue sites, the
MR' macrophages may bind and ingest pathogens directly. Since circulating
phagocytes do not express the MR, the MBP serves an analogous function in the
serum. This acute-phasereactant directly mediates recognition and killing ofmannose-
rich pathogens by neutrophils and monocytes.KUHLMAN ET AL.
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Summary
The human mannose-binding protein (MBP) is a multimeric serum protein that
is divided into three domains: a cysteine-rich NH2-terminal domain that stabilizes
the a-helix of the second collagen-like domain, and a thirdCOOH-terminal carbo-
hydrate binding region. The function of MBP is unknown, although a role in host
defense is suggested by its ability to bind yeast mannans. In this report we show
that native and recombinant human MBP can serve in an opsonic role in serum
and thereby enhance clearance ofmannose rich pathogens by phagocytes. MBP binds
to wild-type virulent Salmonella montevideo that express a mannose-rich 0-polysaccharide.
Interaction ofMBP with these organisms results in attachment, uptake, and killing
of the opsonized bacteria by phagocytes. These results demonstrate that MBP plays
a role in first line host defense against certain pathogenic organisms.
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before publication. We also thank Marsha Kartzman for excellent help in preparation ofthis
manuscript.
Receivedfor publication 3 November 1988 and in revisedform 12January 1989.
References
1 . Russell, D., and S. D. Wright. 1988. Complement type 3 receptor (CR3) binds to an
RGD containing region of the major surface glycoprotein, gp63, of Leishmania
promastigotes. J Exp. Med. 168:279.
2 . Brown, E. J. 1985. Interaction ofgrampositive microorganisms with complement. Curr.
Top. Microbiol. Immunol. 121:159.
3 . Salmon, J. E., S. Kapur, and R. P Kimberly. 1987. Opsonin-independent ligation of
Fc Gamma receptors. The 3G8-bearing receptors on neutrophils mediate the phagocy-
tosis ofConcanavalin-A treated erythrocytes and non-opsonized Escherichia coli.J Exp.
Med. 166:1798.
4. Wright, S. D., and M. T. C. Jong. 1986. Adhesion promoting receptors on human mac-
rophages recognize Escherichia coli by binding tolipopolysaccharide.j Exp. Med 164:1876.
5 . Bar-Shavit, Z., I. Olek, R. Goldman, D. Mirelman, and N. Sharon. 1977. Mannose
residues on phagocytes as receptors for attachmentofEscherichia coli and Salmonella yphi.
Biochem. Biophys. Res. Commun. 78:455.
6. Silverblatt, F. J., J. S. Dreyer, and S. Schauer. 1979. Effect of pili on susceptibility of
Escherichia coli to phagocytosis. Infect. Immun. 24:218.
7 . Bar-Shavit, Z., R. Goldman, I. Ofek, N. Sharon, and D. Mirelman. 1980. Mannose-
binding activity ofEscherichia coli: a determinant ofattachment and ingestion ofthe bac-
teria by macrophages. Infect. Immun. 29:417.
8. Ofek, I., and E. H . Beachey. 1980. Bacterial adherence. Adv. Intern. Med. 25:503.
9. Czop, J. K., and K. F Austen. 1985. A glucan-inhibitable receptor on human mono-
cytes: its identity with the phagocytec receptor for particulate activators ofthe alternative
complement pathway. J. Immunol. 134:2588.
10. Ezekowitz, R. A. B., R. Sim, M. Hill, and S. Gordon. 1984. Local opsonization by secreted
macrophage components. Role of receptors for complement in uptake of zymosan. J.
Exp. Med. 159:244.1744 HUMAN MANNOSE-BINDING PROTEIN FUNCTIONS AS AN OPSONIN
11 . Ezekowitz, R. A. B., and P. S. Stahl. 1988. The structure-function ofvertebrate mannose
lectin-like proteins. J Cell Sci. Suppl. 9:121.
12 . Sung, S. J ., R. S. Nelson, and S. C. Silverstein. 1983. Yeast mannan inhibit binding
and phagocytosis of zymosan by mouse peritoneal macrophages. J Cell Biol. 96:160.
13 . Berton, G., and S. Gordon. 1983. Modulation of macrophage mannosyl-specific receptors
by cultivation on immobilised zymosan. Effects on superoxide-anion release and phago-
cytosis. Immunology. 49:705.
14 . Rouzer, C. A., W. A. Scott, A. L . Hamill, and Z. A. Cohn. 1982. Synthesis of leukotriene
C and other arachidonic acid metabolites by mouse pulmonary macrophages. J Exp.
Med. 155 :720.
15 . Palva, E. T., and P. H. Makela. 1980. Lipopolysaccharide heterogeneity in Salmonella
typhimurium analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. Eur.
J Biochem. 107:116.
16 . Sutherland, I. W. 1985. Biosynthesis and composition of gram-negative bacterial extracel-
lular cell wall polysaccharides. Annu. Rev. Microbiol. 39:243 .
17 . Hunter, S. W., H. Gaylord, and P. Brennan. 1986 . Structure and antigeneity of the phos-
phorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli.J Biol. Chem.
261 :12345.
18 . Tonn, S.J., andJ. E. Gander. 1979. Biosynthesis ofpolysaccharides by prokaryotes. Annu.
Rev. Microbiol. 33:169.
19 . Pistole, T. G. 1981. Interaction of bacteria and fungi with lectins and lectin-like sub-
stances. Annu. Rev. Microbiol. 35:85.
20 . Kawasaki, T., R. Eton, and I. Yamashura. 1978 . Isolation and characterization of a
mannose-binding protein from rabbit liver. Biochem. Biophys. Res. Commun. 81:1018.
21 . Townsend, R., and P. Stahl. 1981 . Isolation and characterization of a mannose/N-
acetylglucosamine/fucose binding protein from rat liver. Biochem. J 194:209.
22 . Kawasaki, N., T. Kawasaki, and I. Yamashura. 1983. Isolation and characterization of
a mannose-binding protein from human serum. J. Biochem. 94:937 .
23 . Wild, J., D. Robinson, and B. Winchester. 1983. Isolation of mannose-binding proteins
from human liver. Biochem. J 210:167.
24 . Summerfield, J. A., and M. E. Taylor. 1986. Mannose-binding proteins human serum:
identification of mannose-specific immunoglobulins and a calcium dependent lectin, of
broader carbohydrate specificity secreted by hepatocytes. Biochem. Biophys. Acta. 883 :197 .
25 . Mizuno, Y., Y. Kozutsumi, T. Kawasaki, and I. Yamashina. 1981. Isolation and charac-
terization of a mannose-binding protein from rat liver. J Biol. Chem. 256:4247.
26. Maynard, Y., and J . U. Baenziger. 1982. Characterization of a mannose and N-ace-
tylglucosamine-specific lectin present in rat hepatocytes. J Biol. Chem. 257 :3708.
27 . Drickamer, K., M. S. Dordal, and L. Reynolds. 1986 . Mannose-binding proteins iso-
lated from rat liver contain carbohydrate-recognition domains linked to collagenous tail.
J Biol. Chem. 261 :6578.
28. Ezekowitz, R. A. B., L. Day, and G. Herman. 1988 . A human mannose-binding protein
is an acute phase reactant that shares sequence homology with other vertebrate lectins.
J Exp. Med. 167 :1034 .
29. Ezekowitz, R. A. B., M. Kuhlman, J. Groopman, and R. Byrn. 1989. A human serum
mannose-binding protein inhibits in vitro infection by the human immunodeficiency
virus. J Exp. Med. 169:185.
30. Montagnier, L., F. Clavel, B. Krust, S. Chamaret, R. Rey, F. Barre-Sinoussi, and J . C.
Chamon. 1978. Identification and antigeneity of the major glycoprotein of lym-
phoadenopathy associated virus. Virology. 144:283.
31 . Grossman, M., and L . Lieve. 1984. Complement activation via the alternative pathwayby purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen
length. J. Immunol. 132:376.
32. Szmeleman, S., and M. Hofrung. 1975. Maltose transport in Escherichia coli K-12: in-
volvement of bacteriophage Lambda receptor. f. Bacteriol. 124:112.
33. van der Lay, P, P de Graeff, and J. Tommassen. 1986. Shielding ofEscherichia coli outer
membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains
of lipopolysaccharide. J Bacteriol. 168:449.
34 . Joiner, K. A. 1988. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol.
42:201 .
35 . Ezekowitz, R. A. B., J. Austyn, P. D. Stahl, and S.
of Bacillus Calmette-Guerin activated mouse
mannose-specific endocytosis, Fc receptors and
of Ia. ,J Exp. Med. 154:60.
36 . Elbein, A. D., and E. C. Heath. 1965 . The biosynthesis
37 .
38.
39 .
40.
42.
43.
44.
45.
46 .
47 .
48 .
KUHLMAN ET AL.
￿
1745
Gordon. 1981 . Surface properties
macrophages: reduced expression of
antigen F4/80 accompanies induction
of cell wall lipopolysaccharide
in Escherichia coli. I. The biochemical properties of a uridine diphosphate galactose-4-
empimeraseless mutant. J. Biol. Chem. 240:1919.
Ofek, I., and N. Sharon. 1988. Lectinophagocytosis : a molecular mechanism ofrecogni-
tion between cell surface sugars and lectins in the phagocytosis of bacteria. Infect. Immun.
56:539.
Kaufman, R. J., P. Murtha, and M. V. Davies. 1987. Translational efficiency ofpolycis-
tronic mRNAs and their utilization to express heterologous genes in mammalian cells.
Embo 6:187.
Grossman, N., M. A. Schmetz, J. Foulds, E. N. Klima, V. Jiminez, L. L. Leive, and
K. A. Joiner. 1987. Lipopolysaccharide size and distribution determine serum resistance
in salmonella montevideo. J. Bacteriol. 169:856.
van der Lay, P, O. Kuipers, J. Tommassen, and B. Lugtenberg. 1986. O-antigenic chains
oflipopolysaccharide prevent binding of antibody molecules to an outer membrane pore
protein in Enterobacteriaceae. Microb. Pathog. 1:43.
Mizuochi, T, M. W. Spellman, M . Larkin, J. Solomon, L. J. Basu, and T. Feizi. 1988.
Carbohydrate structures of the human immunodeficiency virus (HIV) and recombinant
envelope glycoprotein gp120 produced in Chinese Hamster Ovary cells. Biochem.f. 254:599.
Reid, K. B. M. 1983. Proteins involved in the activation and control of the two pathways
of human complement. Biochem. Soc. Trans. 11:1.
Weinbaum, D. L., J . A. Sullivan, and G. L. Mandell. 1980. Receptors for concanavalin
A cluster at the front of polarized neutrophils. Nature (Loud.). 286:725.
Carrington, D. M., A. Auffret, and D. E. Hank. 1985. Polypeptide ligation occurs during
post-translational modification of concanavalin A. Nature (Loud.). 313 :64.
Tenner, A. J., and N. R. Cooper. 1981. Identification of types of cells in human periph-
eral blood that bind Clq. j Immunol. 126 :1174.
Ghebrehiwet, B., L. Silvestri, and C. McDevitt. 1984. Identification of the Raji cell
membrane-derived Clq inhibitor as a receptor for human Clq. J Exp. Med. 160:1375.
Hynes, R. O. 1988 . Integrins: a family of cell surface receptors. Cell. 48 :549.
Ikeda, K., T Sannoh, N. Kawasaki, T Kawasaki, and I. Yamashina. 1987 . Serum lectin
with known structure activates complement through the classical pathway.J. Biol. Chem.
262:7451.